Correction to: Anti-PD-1 antibodies as a salvage therapy for patients with diffuse large B cell lymphoma who progressed/relapsed after CART19/20 therapy

Affiliations

Chunmeng Wang: Department of Bio-Therapeutic, The First Medical Centre in Chinese PLA General Hospital
Fengxia Shi: Department of Bio-Therapeutic, The First Medical Centre in Chinese PLA General Hospital
Yang Liu: Department of Bio-Therapeutic, The First Medical Centre in Chinese PLA General Hospital
Yajing Zhang: Department of Bio-Therapeutic, The First Medical Centre in Chinese PLA General Hospital
Liang Dong: Department of Bio-Therapeutic, The First Medical Centre in Chinese PLA General Hospital
Xiang Li: Department of Bio-Therapeutic, The First Medical Centre in Chinese PLA General Hospital
Chuan Tong: Department of Bio-Therapeutic, The First Medical Centre in Chinese PLA General Hospital
Yao Wang: Department of Bio-Therapeutic, The First Medical Centre in Chinese PLA General Hospital
Liping Su: Department of Hematology, Shanxi Cancer Hospital
Jing Nie: Department of Bio-Therapeutic, The First Medical Centre in Chinese PLA General Hospital
Weidong Han: Department of Bio-Therapeutic, The First Medical Centre in Chinese PLA General Hospital

Abstract

No abstracts available.

ISSN: 1756-8722 (Online)
Publisher: BMC
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs; Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jhoonline.biomedcentral.com/